Drug-induced myocarditis precipitated by amlodipine overdose: a case report.

Amlodipine Amlodipine overdose Calcium channel blocker Cardiovascular pharmacology Case report Myocarditis Toxic myocarditis

Journal

European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 24 07 2023
revised: 17 01 2024
accepted: 25 03 2024
medline: 5 4 2024
pubmed: 5 4 2024
entrez: 5 4 2024
Statut: epublish

Résumé

Amlodipine is the most commonly prescribed calcium channel blocker (CCB), used in the treatment of a variety of cardiovascular conditions. Calcium channel blockers remain a well-established cause of cardiovascular drug overdose. We present the case of an intentional overdose with 250 mg of amlodipine resulting in acute left ventricular dysfunction and myocarditis. A 46-year-old man with no significant past medical history presented to the emergency department 8 h after intentionally ingesting 250 mg of amlodipine. Although initially asymptomatic with unremarkable physical examination, the patient developed progressively worsening dyspnoea over the next 2 days. Subsequent findings from chest X-ray, electrocardiogram, echocardiogram, and cardiac magnetic resonance imaging (MRI) were consistent with a diffuse myocarditis process with severe left ventricular systolic dysfunction. The patient was managed with diuretics and discharged once stable. Our case highlights myocarditis as a potential complication of CCB overdose. Amlodipine is the most commonly prescribed CCB and is associated with cardiac toxicity at high doses. The long duration of action and high volume of distribution of amlodipine further increase the risk of morbidity and mortality from overdose. Known cardiac complications of amlodipine overdose include bradycardia, myocardial depression, and pulmonary oedema secondary to heart failure; however, diffuse myocarditis is a complication that has not previously been described in the literature. The mechanism of development of this complication remains unclear.

Sections du résumé

Background UNASSIGNED
Amlodipine is the most commonly prescribed calcium channel blocker (CCB), used in the treatment of a variety of cardiovascular conditions. Calcium channel blockers remain a well-established cause of cardiovascular drug overdose. We present the case of an intentional overdose with 250 mg of amlodipine resulting in acute left ventricular dysfunction and myocarditis.
Case summary UNASSIGNED
A 46-year-old man with no significant past medical history presented to the emergency department 8 h after intentionally ingesting 250 mg of amlodipine. Although initially asymptomatic with unremarkable physical examination, the patient developed progressively worsening dyspnoea over the next 2 days. Subsequent findings from chest X-ray, electrocardiogram, echocardiogram, and cardiac magnetic resonance imaging (MRI) were consistent with a diffuse myocarditis process with severe left ventricular systolic dysfunction. The patient was managed with diuretics and discharged once stable.
Discussion UNASSIGNED
Our case highlights myocarditis as a potential complication of CCB overdose. Amlodipine is the most commonly prescribed CCB and is associated with cardiac toxicity at high doses. The long duration of action and high volume of distribution of amlodipine further increase the risk of morbidity and mortality from overdose. Known cardiac complications of amlodipine overdose include bradycardia, myocardial depression, and pulmonary oedema secondary to heart failure; however, diffuse myocarditis is a complication that has not previously been described in the literature. The mechanism of development of this complication remains unclear.

Identifiants

pubmed: 38576465
doi: 10.1093/ehjcr/ytae161
pii: ytae161
pmc: PMC10993021
doi:

Types de publication

Case Reports

Langues

eng

Pagination

ytae161

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

Déclaration de conflit d'intérêts

Conflict of interest: None declared.

Auteurs

Maria Skaria (M)

University of Birmingham Medical School, Vincent Drive, Edgbaston, Birmingham B15 2TT, UK.

Edward Hoey (E)

Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Richard Watkin (R)

Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Binoy Skaria (B)

Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Classifications MeSH